Full-Time
Senior Software Engineer
Posted on 9/1/2025
Wisp
51-200 employees
Telehealth for sexual and reproductive care
Compensation Overview
$150k - $175k/yr
No H1B Sponsorship
Remote in USA
Remote
 Software Engineering (1) |
|---|
- Minimum 4+ years of experience in a Full-Stack Engineering role.
- 4+ years of experience with Python, demonstrating strong knowledge of language fundamentals, libraries, and best practices. Flask experience is a plus.
- 4+ years experience with JavaScript and at least 2+ years of experience with a modern front end framework like React, Vue, or Angular. NextJS experience is a plus.
- 4+ years experience with relational database systems - PostgreSQL (preferred) or MySQL
- Professional experience working in a cloud-based environment - AWS (preferred), GCP, Azure.
- Visa sponsorship or transfer is not available for this position at present. Must be authorized to work in the country this requisition states.
- Build For Our Patients: Keep patients at the center of technical decisions while advocating for privacy, security, and access to care. Connect technical work to patient outcomes through thoughtful implementation.
- Technical Execution: Contribute to architectural decisions and implement technical standards through code reviews, design discussions, and high-quality code. Balance speed with building reliable, well-structured, extensible solutions.
- Cross-Functional Collaboration: Partner with Product Managers, Designers, and stakeholders on complex projects. Communicate technical concepts clearly and identify potential risks proactively.
- Mentorship & Growth: Serve as a technical resource and example for other engineers on the team. Share knowledge through clear documentation and thoughtful code reviews. Provide guidance when needed and help maintain quality standards across engineering deliverables.
- Technical Leadership: Identify improvement opportunities within your team's scope and contribute to technical discussions that shape project direction.
- Flask experience is a plus.
- NextJS experience is a plus.
- AWS (preferred) experience is a plus.
- Experience working with protected health information or in a regulated environment is a plus.
Wisp provides telehealth-based sexual and reproductive healthcare. It offers online consultations with qualified clinicians, including women’s health nurse practitioners, followed by prescriptions that can be picked up the same day or shipped to patients for free. The company also sells at-home testing kits for STIs, fertility, and vaginal health, expanding access to testing without in-person visits. Patients access services through a discreet, judgment-free online experience, which is especially appealing to those without insurance or who value privacy and convenience. Revenue comes from consultation fees and the sale of prescribed medications, with an affiliate program helping partners promote the service and grow the customer base. Wisp’s goal is to make affordable, private, and convenient sexual and reproductive healthcare available to more people, removing barriers related to cost, stigma, and access.
Company Size
51-200
Company Stage
Acquired
Total Funding
$41M
Headquarters
San Francisco, California
Founded
2018
Simplify's Take
What believers are saying
- Serves 1.8 million patients nationwide across all 50 states.
- Expands fertility care via Proov and PherDal at-home testing kits.
- Recognized by Inc. and TIME as Best in Business 2025.
What critics are saying
- Class action lawsuit accuses Wisp of sharing patient data with Facebook.
- Planned Parenthood and CVS expand same-day STI telehealth services.
- GLP-1 drugs suppress sexual function, eroding birth control revenue.
What makes Wisp unique
- Partners with Visby Medical for first FDA-authorized at-home PCR STI test.
- Acquires TBD Health to enter enterprise TelePrEP with Mount Sinai partnerships.
- Launches longevity vertical with NAD+, glutathione, and LDN treatments.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Growth & Insights and Company News
6 month growth
↓ -5%1 year growth
↓ -1%2 year growth
↓ -1%Wisp launches women-focused longevity and healthy aging vertical.
Wisp, the largest women's telehealth company in the US, has launched a new Longevity and Healthy Aging category, expanding into clinician-guided longevity care. The initial offering includes five science-backed treatments: glutathione, NAD+ (both available as nasal spray and injection), and low-dose naltrexone. The launch addresses a significant gap identified in a survey of nearly 2,000 women, where 75% prioritise long-term health but nearly half remain uncertain about effective interventions for female bodies. The company noted that women represent 80% of autoimmune diagnoses and face disproportionate rates of chronic fatigue and cognitive symptoms during perimenopause and menopause. Wisp serves 1.8 million patients nationwide and offers asynchronous consultations with continuous clinician oversight. Future plans include programmes for mitochondrial support, cognitive health and preventive diagnostics.
Wisp, the largest women’s telehealth company in the U.S., today announced the acquisition of TBD Health, a national sexual health platform and one of the nat...
Wisp acquires sexual health platform TBD Health, expands into hybrid and enterprise care. Wisp, a US-based women's telehealth company, has acquired TBD Health, a sexual health platform operating across all 50 states. The deal terms were not disclosed. This marks Wisp's first acquisition and expands the company beyond direct-to-consumer care into enterprise and hybrid care models. TBD Health operates a sexual health and diagnostics platform offering STI and HIV testing, TelePrEP services, and virtual clinical support. The company has partnerships with Mount Sinai Health System, San Francisco AIDS Foundation, and Planned Parenthood Direct. "This acquisition reflects where healthcare is going and where women have been left behind," said Monica Cepak, CEO of Wisp. "TBD Health brings the infrastructure and partnerships that allow us to move into hybrid and enterprise care quickly, while staying true to Wisp's patient-first approach. Together, we are making preventative care more accessible especially to women and integrating them into proven care models." The acquisition addresses gaps in PrEP access for women. While women account for 19% of new HIV diagnoses in the United States, according to the company, most prevention models have historically been designed and marketed for men. Of the 2.4 million people eligible for PrEP treatment, only approximately 25% are currently enrolled. "By joining forces with Wisp, we can provide partners with a turnkey solution for PrEP along with sexual health diagnostics and care that integrates seamlessly into their existing workflows, ensuring no patient falls through the cracks," said Daphne Chen, co-founder of TBD Health. Wisp reports serving 1.8 million patients across the United States. The company is majority-owned by WELL Health Technologies Corp. TBD Health was co-founded by Stephanie Estey, Daphne Chen, and Sherwin Lu.
What You Should Know:– Wisp, the largest U.S. telehealth company focused exclusively on women’s sexual and reproductive health, has launched its new diagnostics vertical, significantly expanding its service offerings.– With over 1.5 million patients across all 50 states, Wisp is now providing convenient, affordable at-home testing for common sexually transmitted infections (STIs), coupled with integrated follow-up care within its existing virtual ecosystem.Wisp Launches Nationwide At-Home STI Testing to Expand Access to Women’s Diagnostic CareWisp is the largest pure-play women’s telehealth provider in the United States, delivering discreet, evidence-based treatments and a first-to-market product line across sexual and reproductive health. With services spanning all 50 states, Wisp continues to establish itself as a leading, all-in-one platform for women’s health.The new Wisp At-Home Testing Follow-Up Care service allows patients to:· Collect swab and urine samples from home· Ship samples to a CLIA/CAP-accredited lab using a prepaid label· Receive accurate results within 3–5 business days· Access discreet, evidence-based follow-up care through Wisp’s clinical teamThis launch addresses rising barriers in healthcare access, including nationwide provider shortages and stigma around STI testing. It also eliminates the previous need for third-party referrals by keeping the entire diagnostic and care process within Wisp’s system.Initial offerings include:· Common STI Panel: Tests for Chlamydia, Gonorrhea, and Trichomoniasis· 3-Site Panel: Detects Chlamydia and Gonorrhea from three anatomical sites· M-Gen Panel: Screens for Mycoplasma Genitalium (Mgen)Future plans include additional testing options in upcoming quarters, including hormonal health diagnostics and in-home blood draw services to bolster the fertility and menopause verticals.Survey data from Wisp shows that:· 62% of users express interest in STI testing· STI, STD, and Herpes-related queries are up 40% year-over-year· STIs such as Chlamydia, Gonorrhea, and Trichomoniasis disproportionately affect women under 25According to Wisp CEO Monica Cepak, integrating diagnostics into the platform was a natural evolution, aligning with the company’s mission to deliver 360-degree care through affordability, discretion, and convenience. All test kits are priced at the lowest market rates and include free virtual consultations for follow-up.Dr. Jillian LoPiano, MD, MPH, FACOG, emphasized the clinical impact of discreet, reliable diagnostics, noting their potential to destigmatize sexual health and empower women to proactively manage their care